Morgan Stanley lowered the firm’s price target on Cinemark (CNK) to $34 from $35 and keeps an Overweight rating on the shares. The 2025 box office looks to grow 5% year-over-year, which would be “healthy but below initial expectations,” says the analyst. The firm’s estimates remain “modestly above consensus” in 2026, but it is now taking a more conservative approach, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNK:
- Cinemark price target raised to $38 from $37 at JPMorgan
- Positive Outlook for Cinemark Holdings Driven by Strong Film Lineup, Financial Position, and Strategic Diversification
- Taylor Swift plans return to movie theaters, Hollywood Reporter says
- Cinemark, Rokt expand partnership
- Cinemark management to meet with Benchmark